MTOR and prostate cancer: Kim et al. [16] demonstrated that OTUD7B enhances prostate cancer cell proliferation and autophagy, and inhibits apoptosis via the protein kinase B/mammalian target of rapamycin (AKT/mTOR) signaling pathway.